China (Mainland)
Nolvadex CAS NO.54965-24-1
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,
- Product Details
Keywords
- 54965-24-1 TMX
- Tamoxifen? Citrate
- breast cancer medicine
Quick Details
- ProName: Nolvadex
- CasNo: 54965-24-1
- Molecular Formula: C32H34NO8
- Appearance: white to off-white crystalline powder
- Application: treat breast cancer
- DeliveryTime: Please contact us for details
- PackAge: 1kg/bag, 25kg/drum
- Port: Shanghai, Tianjin ,Qingdao, Ningbo, Xi...
- ProductionCapacity: 100 Kilogram/Month
- Purity: 99%+
- Storage: Preserve in well-closed, light-resista...
- Transportation: By courier, by air
- LimitNum: 1 Kilogram
- Residue on Ignition: not more than 0.2%
- Heavy Metal: 0.001%
- Loss on drying: Maximum 0.5%
- E-isomer: not more than 0.3%
Superiority
XI'AN VEDA CHEMICAL CO.,LTD, is specializes in APIs and Intermediates, as well as fine chemical products and customer synthesis.
Although don't have long history, the company has an increasing output products. Our products have been exporting to South America,
Southeast Asia, Europe and other regions, and has gained excellent reputation.
To decrease the pain of the patient is our mission.
We are trying every effort to make the worlds more healthier and happier.
Tamoxifen Citrate is commonly prescribed for:
1) Blocking the effects of estrogen
2) Treatment of breast cancer
3) Decreases the chance of breast cancer coming back in women who have received treatment for the disease
4) May help prevent breast cancer in women who have a high risk of developing breast cancer.
If you are pharmaceutical company that are searching for Tamoxifen
Citrate, or you are a trading company that are looking for effective
products to treat breast cancer, please contact us.
We would like to offer our best quotation for you. What's more, the COA/MSDS/MOA of Tamoxifen Citrate can be offered.
We, Xi'an Veda Chemical, is ready to make long term cooperation with you.
Details
|
product Name |
Tamoxifen citrate |
|
Synonyms |
(z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxyl]-n,n-dimethyl-ethanamine-citrate; 1-p-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene citrate; Tamoxiphen Citrate; 2-{4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt) |
|
Molecular Formula |
C32H34NO8 |
|
Molecular Weight |
560.6159 |
|
InChI |
InChI=1/C26H29NO.C6H8O7/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3;7-3(8)1-6(13,5(11)12)2-4(9)10/h5-18H,4,19-20H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/p-3/b26-25-; |
|
CAS Registry Number |
54965-24-1 |
|
EINECS |
259-415-2 |
|
Molecular Structure |
|
|
Melting point |
140-144℃ |
|
Water solubility |
slightly soluble |
|
Hazard Symbols |
|
|
Risk Codes |
R22:; |
|
Safety Description |
S45:; |
T:Toxic;
|
Characters |
White or almost white, crystalline powder |
|
Identification |
IR: Complies with the CRS |
|
|
Ultraviolet Absorption: Complies with working standard |
|
Loss on drying |
Not more than 0.5% |
|
Residue on ignition |
Not more than 0.2% |
|
Limit of E-isomer |
Not more than 0.3% |
|
Iron |
Maximum 50ppm |
|
Heavy metals |
Maximum 10ppm |
|
Related impurities |
Single peak area: not greater than 0.5% |
|
|
Total peak area: not greater than 1.0% |
|
Assay |
Tamoxifen Citrate contains not less and 99.0% percent and not more than 101.0 percent of C26H29NO·C6H8O7, calculated on the dried basis |
